<DOC>
	<DOCNO>NCT02002663</DOCNO>
	<brief_summary>The aim study identification , compare continuous infusion local anesthetic steroid intralesionally current gold standard therapy ( PCA ) , effective dose local anesthetic steroid within 7 day follow abdominal surgery order halve consumption opioids give best pain control low incidence side effect persistent chronic pain ( 1 3 month ) We also plan measure peripheral inflammation oxidative stress analyze pro-inflammatory cytokine anti-inflammatory property . Another objective investigate combine effect polymorphism gene relate pain sensitivity , correlation development inflammatory response incidence chronic post-surgical pain ( CPSP ) , consider validate genotype-phenotype correlation . The intralesional catheter place within operating field surgeon end procedure . - first postoperative 24 hour : ropivacaine 0.2 % -methylprednisolone 1 mg/kg/die infusion ( 10ml/h ) wound . Rescue dose morphine via intravenous PCA ( 0.5 mg/ml , bolus 1 mg , lock-out 5 min , max 20 mg 4 hour ) - 24 h 48 h : ropivacaine 0.2 % -methylprednisolone 1 mg/kg/die infusion ( 10ml/h ) saline 0.9 % 10 ml/h wound . Rescue dose morphine via intravenous PCA ( 0.5 mg/ml , bolus 1 mg , lock-out 5 min , max 20 mg 4 hour ) . 48 hs 7th day : ropivacaine 0.2 % saline 0.9 % via patient control intralesional analgesia ( PCIA ) ( 2 mg/ml , bolus 20 mg , lock-out 60 min , max 80 mg 4 hour ) . Rescue dose Tramadol 100 mg . The first assessment anesthetist pre-operatively , verify patient eligibility . All patient evaluate end surgery ( T0 ) 3-6-12-24-36-48 hour surgery . Further evaluation schedule every 24 hour seventh postoperative day . At assessment record : Numeric Rating Scale ( NRS ) rest , NRS movement ( NRSm ) - define pain deep inspiration cough - ; blood pressure , heart rate , respiratory rate , nausea ( PONV scale ) , need rescue analgesic presence complication . On 7th postoperative day , patient reassess pain clinician surgeon ; surgeon remove catheter . At 1 month 3 month surgery , patient evaluate phone interview investigate pain persistence . Inflammatory response analysis perform first 15 patient group ( total 30 patient ) . Before awaken patient surgeon insert microdialysis catheter fat adjacent surgical wound sterile technique . The microdialysed liquid collect dedicated tube directly infusion pump . The sample first hour discard avoid microtrauma catheter position influence study . Sampling perform every 6 hour first day , every 12 hour second third day . Serum sample collect compare systemic regional sample . All sample store -80 Â° C sample . Concentrations quantification different cytokine analyze ELISA Parma Unit analyze VNTR ( variable number tandem repeat ) polymorphism ADRB2 gene , directly relate risk chronic persistent postoperative pain development ; Pavia Unit take care genotyping polymorphic site follow gene : OPRM1 ( mu-opioid receptor 1 ) , COMT ( catecholamine O-methyl transferase ) , UGT2B7 ( UDP-glucuronyl transferase ) , IL1Ra ( interleukin 1receptor alpha ) . From blood sample extract DNA RNA use standard procedure . RNA retain possible future study expression gene interest . The DNA use instead study genetic polymorphism . In study formation free radical , particularly superoxide assess together lipid peroxidation serum urine , The 8- deoxyguanosine Poly-ADP-ribose polymerase ( PARP ) , presence nitrotyrosine . Blood sample urine test carry start surgery , bolus morphine local anesthetic , 24 h end intervention 48 h end intervention</brief_summary>
	<brief_title>Continuous Local Anesthetic Steroid Infusion Abdominal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Male female 1885 year old schedule use PCA morphine postoperative pain control HIVnegative Classification American Society Anesthesiologists ( ASA ) I : without systemic disease Classification ASA II III ( moderate systemic disease severe systemic disease limit activity without disability ) Scheduled major abdominal urologic surgery ( emergency surgery ) regular use opioid analgesic ; History abuse drug / alcohol ; Postoperative hospitalization intensive care sedation / mechanical ventilation ; severe renal impairment ( creatinine &gt; 2 g / dl , creatinine clearance &lt; 30 ml / h ) / hepatic impairment ( cholinesterase &lt; 2000 IU ) ; Cardiac disorder ( arrhythmia , heart failure ) ; Neurological disorder ( epilepsy ) ; Cognitive disorder , mental retardation , psychiatric disorder ; Changes normal coagulation coagulopathy ( INR &gt; 2 , PTT &gt; 44 sec ) ; Platelet count le 100.000/mm3 ; BMI &gt; 30 ; Allergy study drug . diabetes type I/II</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>